| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |